Table 3 Regression analysis for changes in SAA–LDL and CAVI during treatment with EPA

From: Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome

 

ΔSAA–LDL

ΔCAVI

 

Univariate

Multivariate

Univariate

Multivariate

ΔBW

0.191

—

−0.083

—

ΔBMI (kg m−2)

0.255

—

−0.025

—

ΔWaist circumference

0.090

—

0.004

—

ΔSystolic blood pressure

−0.137

—

0.218

—

ΔDiastolic blood pressure

−0.110

—

0.066

—

ΔFasting plasma glucose

0.147

—

0.101

—

ΔHbA1c

−0.066

—

−0.068

—

ΔIRI

−0.044

—

−0.037

—

ΔTotal cholesterol

0.360*

0.293*

0.278

—

ΔLDL-C

−0.005

—

−0.075

—

ΔHDL-C

0.081

—

−0.141

—

ΔTriglyceride

0.287

—

0.160

—

ΔSAA–LDL

  

0.381*

0.381*

ΔLeptin

0.003

—

0.211

—

ΔAdiponectin

−0.331*

−0.305*

−0.213

—

ΔCRP

0.365*

—

0.158

—

ΔPWV

0.366*

—

  

ΔCAVI

0.381*

0.325*

  
  1. Abbreviations: BMI, body mass index; CAVI, cardio-ankle vascular index; CRP, high-sensitive C-reactive protein; EPA, eicosapentaenoic acid; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; IRI, immunoreactive insulin; LDL-C, low-density lipoprotein cholesterol; PWV, pulse wave velocity; SAA–LDL, serum amyloid A–LDL.
  2. Multivariate regression analysis was performed with adjustments for all metabolic parameters as independent variables.
  3. *P<0.05.
Back to article page